CompletedPhase 1NCT01652794
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Studying Sex cord-stromal tumor of testis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Case Comprehensive Cancer Center
- Principal Investigator
- Steven Waggoner, MDCase Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
- Intervention
- stereotactic body radiation therapy(radiation)
- Enrollment
- 12 enrolled
- Eligibility
- 19 years · FEMALE
- Timeline
- 2012 – 2015
Study locations (1)
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01652794 on ClinicalTrials.gov